These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


230 related items for PubMed ID: 32411127

  • 1. A Treg-Selective IL-2 Mutein Prevents the Formation of Factor VIII Inhibitors in Hemophilia Mice Treated With Factor VIII Gene Therapy.
    Chen AC, Cai X, Li C, Khoryati L, Gavin MA, Miao CH.
    Front Immunol; 2020; 11():638. PubMed ID: 32411127
    [Abstract] [Full Text] [Related]

  • 2. CD4+ T cells engineered with FVIII-CAR and murine Foxp3 suppress anti-factor VIII immune responses in hemophilia a mice.
    Fu RY, Chen AC, Lyle MJ, Chen CY, Liu CL, Miao CH.
    Cell Immunol; 2020 Dec; 358():104216. PubMed ID: 32987195
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. CD4+FOXP3+ regulatory T cells confer long-term regulation of factor VIII-specific immune responses in plasmid-mediated gene therapy-treated hemophilia mice.
    Miao CH, Harmeling BR, Ziegler SF, Yen BC, Torgerson T, Chen L, Yau RJ, Peng B, Thompson AR, Ochs HD, Rawlings DJ.
    Blood; 2009 Nov 05; 114(19):4034-44. PubMed ID: 19713458
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Higher frequency of CD4(+)CD25(high) Treg cells in hemophilia patients with factor VIII inhibitor.
    Ding KY, Ji WC, Wu JS, Li T, Sheng YY.
    Genet Mol Res; 2014 Mar 17; 13(1):1774-81. PubMed ID: 24668665
    [Abstract] [Full Text] [Related]

  • 10. Immune tolerance induced by platelet-targeted factor VIII gene therapy in hemophilia A mice is CD4 T cell mediated.
    Chen Y, Luo X, Schroeder JA, Chen J, Baumgartner CK, Hu J, Shi Q.
    J Thromb Haemost; 2017 Oct 17; 15(10):1994-2004. PubMed ID: 28799202
    [Abstract] [Full Text] [Related]

  • 11. Antigen-specific in vitro expansion of factor VIII-specific regulatory T cells induces tolerance in hemophilia A mice.
    Smith BM, Lyle MJ, Chen AC, Miao CH.
    J Thromb Haemost; 2020 Feb 17; 18(2):328-340. PubMed ID: 31609041
    [Abstract] [Full Text] [Related]

  • 12. In vivo induction of regulatory T cells for immune tolerance in hemophilia.
    Wang X, Terhorst C, Herzog RW.
    Cell Immunol; 2016 Mar 17; 301():18-29. PubMed ID: 26454643
    [Abstract] [Full Text] [Related]

  • 13. Genetic induction of immune tolerance to human clotting factor VIII in a mouse model for hemophilia A.
    Evans GL, Morgan RA.
    Proc Natl Acad Sci U S A; 1998 May 12; 95(10):5734-9. PubMed ID: 9576953
    [Abstract] [Full Text] [Related]

  • 14. Naked DNA transfer of Factor VIII induced transgene-specific, species-independent immune response in hemophilia A mice.
    Ye P, Thompson AR, Sarkar R, Shen Z, Lillicrap DP, Kaufman RJ, Ochs HD, Rawlings DJ, Miao CH.
    Mol Ther; 2004 Jul 12; 10(1):117-26. PubMed ID: 15233948
    [Abstract] [Full Text] [Related]

  • 15. B Cell Depletion Eliminates FVIII Memory B Cells and Enhances AAV8-coF8 Immune Tolerance Induction When Combined With Rapamycin.
    Biswas M, Palaschak B, Kumar SRP, Rana J, Markusic DM.
    Front Immunol; 2020 Jul 12; 11():1293. PubMed ID: 32670285
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.